share_log

Chardan Capital Initiates Coverage On Anixa Biosciences With Buy Rating, Announces Price Target of $8

Chardan Capital Initiates Coverage On Anixa Biosciences With Buy Rating, Announces Price Target of $8

Chardan Capital以买入评级开始对Anixa Biosciences进行报道,宣布目标股价为8美元
Benzinga Real-time News ·  2022/12/23 05:41

Chardan Capital analyst Matthew Barcus initiates coverage on Anixa Biosciences (NASDAQ:ANIX) with a Buy rating and announces Price Target of $8.

Chardan Capital分析师马修·巴库斯以买入评级启动对Anixa Biosciences(纳斯达克:ANIX)的报道,并宣布目标价为8美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发